EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut Microbiome in Human Melioidosis: Composition and Resistome Dynamics from Diagnosis to Discovery

Soumi Chowdhury iD, Robert F J Kullberg, Bastiaan W Haak, Claudio Duran, Venkat A Earny iD, Vandana K Eshwara, Trevor D Lawley, W Joost Wiersinga iD, Chiranjay Mukhopadhyay iD

Open Forum Infectious Diseases · 30.10.2024 · 11 (11)

DOI: 10.1093/ofid/ofae654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 05.11.2024. Verfasst von Soumi Chowdhury und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melioidosis, attributable to the soil-dwelling bacterium Burkholderia pseudomallei, stands as a paramount global health challenge, necessitating extended courses of antibiotics. While murine studies identified the gut microbiota as a modulator of bacterial dissemination during melioidosis, the human intestinal microbiota during melioidosis remains uncharacterized. Here, we characterized gut microbiota composition and antimicrobial resistance (AMR) genes at diagnosis, during treatment, and postdischarge for melioidosis. We hypothesized that the gut microbiota of melioidosis patients would be extensively distorted.

Methods

In this prospective observational cohort, stool samples of patients with culture-confirmed melioidosis admitted to a tertiary care hospital in India were collected at diagnosis, 14 days after diagnosis, or discharge (whichever occurred first) and at 6 months postinfection. Family members or neighbors served as community controls. The gut microbiota and resistome were profiled by shotgun metagenomic sequencing.

Results

We longitudinally analyzed the gut microbiota of 70 fecal samples from 28 patients and 16 community controls. At diagnosis, the gut microbiota of patients differed from that of controls, characterized by high abundances of potentially pathogenic bacteria, a loss of butyrate-producing bacteria, and higher levels of AMR genes. Microbiota composition and resistome remained different from community controls at 6 months, driven by total antibiotic exposure. During hospitalization, gut microbiota profiles were associated with secondary Klebsiella pneumoniae infections.

Conclusions

This first study on gut microbiota composition and resistome in human melioidosis showed extensive disruptions during hospitalization, with limited signs of restoration 6 months postinfection. Given the adverse outcomes linked with microbiome perturbations, limiting microbiota disruptions or using microbiota-restorative therapies (eg, butyrate-producing probiotics) may be beneficial.

Schlagwörter

Stichwörter der Autor:innen

AMR genesIndiagut microbiomemelioidosisresistome

Autor:innen und Institutionen

  • Department of Microbiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Center of Emerging and Tropical Diseases (CETD), Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Center for Experimental and Molecular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
  • Center for Antimicrobial Resistance and Education (CARE), Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Division of Infectious Diseases, Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.

ORCID-Profile: Soumi Chowdhury, Venkat A Earny, W Joost Wiersinga, Chiranjay Mukhopadhyay

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Chowdhury, S., Kullberg, R. F. J., Haak, B. W., Duran, C., Earny, V. A., Eshwara, V. K., Lawley, T. D., Wiersinga, W. J., & Mukhopadhyay, C. (2024). Gut Microbiome in Human Melioidosis: Composition and Resistome Dynamics from Diagnosis to Discovery. Open Forum Infectious Diseases, 11(11). https://doi.org/10.1093/ofid/ofae654

Vancouver

Chowdhury S, Kullberg RFJ, Haak BW, Duran C, Earny VA, Eshwara VK, et al. Gut Microbiome in Human Melioidosis: Composition and Resistome Dynamics from Diagnosis to Discovery. Open Forum Infectious Diseases. 2024;11(11). doi:10.1093/ofid/ofae654

BibTeX
@article{Chowdhury2024,
  author = {Chowdhury, Soumi and Kullberg, Robert F J and Haak, Bastiaan W and Duran, Claudio and Earny, Venkat A and Eshwara, Vandana K and Lawley, Trevor D and Wiersinga, W Joost and Mukhopadhyay, Chiranjay},
  title = {Gut Microbiome in Human Melioidosis: Composition and Resistome Dynamics from Diagnosis to Discovery},
  journal = {Open Forum Infectious Diseases},
  year = {2024},
  volume = {11},
  number = {11},
  doi = {10.1093/ofid/ofae654}
}
Kostenlos starten →